The short-chain fatty acid uptake fluxes by mice on a guar gum supplemented diet associate with amelioration of major biomarkers of the metabolic syndrome

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Den Besten, Gijs ^a,b   Havinga, Rick ^a   Bleeker, Aycha ^a,c   Rao, Shodhan ^a   Gerding, Albert ^a   Van Eunen, Karen ^a,b,c   Groen, Albert K ^a,b   Reijngoud, Dirk Jan ^a,b   Bakker, Barbara M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Netherlands Consortium for Systems Biology   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GUAR GUM; INSULIN; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL; GALACTAN; GLUCOSE BLOOD LEVEL; MANNAN; PLANT GUM; VOLATILE FATTY ACID;

ADIPOSE WEIGHT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY WEIGHT; CECUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; IN VIVO STUDY; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; STEADY STATE; ANIMAL; BLOOD; C57BL MOUSE; DIETARY FIBER; GLUCOSE BLOOD LEVEL; LIPID DIET; LIVER; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; CECUM; DIET, HIGH-FAT; DIETARY FIBER; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; GALACTANS; INSULIN; LIVER; MALE; MANNANS; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; PLANT GUMS; TRIGLYCERIDES;

EID: 84925042878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107392     Document Type: Article

References (43)

1. Galisteo M, Duarte J, Zarzuelo A. (2008) Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 19: 71-84.
2. Misra A, Singhal N, Khurana L. (2010) Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: Role of dietary fats and oils. J Am Coll Nutr 29: 289S-301S.
3. Papathanasopoulos A, Camilleri M. (2010) Dietary fiber supplements: Effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 138: 65-72.
4. Butt MS, Shahzadi N, Sharif MK, Nasir M. (2007) Guar gum: A miracle therapy for hypercholesterolemia, hyperglycemia and obesity. Crit Rev Food Sci Nutr 47: 389-396.
5. Dall'alba V, Silva FM, Antonio JP, Steemburgo T, Royer CP, et al. (2013) Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes a randomised clinical trial. Br J Nutr 110: 1601-1610.
6. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D, et al. (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota and host energy metabolism. J Lipid Res 54: 2325-2340.
7. Cook SI, Sellin JH. (1998) Review article: Short chain fatty acids in health and disease. Aliment Pharmacol Ther 12: 499-507.
8. Hu G, Chen G, Xu H, Ge R, Lin J. (2010) Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome. Med Hypotheses 74: 123-126.
9. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509-1517.
10. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, et al. (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13: 517-526.
11. Blouin JM, Penot G, Collinet M, Nacfer M, Forest C, et al. (2010) Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int J Cancer 128: 2591-2601.
12. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, et al. (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682: 39-53.
13. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. (2010) G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int J Cancer 128: 847-856.
14. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, et al. (2008) Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 27: 104-119.
15. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
16. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, et al. (2010) Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut 59: 1635-1642.
17. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18: 190-195.
18. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104: 979-984.
19. Høverstad T, Midtvedt T. (1986) Short-chain fatty acids in germfree mice and rats. J Nutr 116: 1772-1776.
20. Teixeira TFS, Grzes̈kowiaka L, Franceschinia SCC, Bressana J, Ferreira CLLF, et al. (2013) Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr 109: 914-919.
21. Ott SJ, Musfeldt M, Timmis KN, Hampe J, Wenderoth DF, et al. (2004) In vitro alterations of intestinal bacterial microbiota in fecal samples during storage. Diagn Microbiol Infect Dis 50: 237-245.
22. Ebihara K, Schneeman BO. (1989) Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J Nutr 119: 1100-1106.
23. de Wit N, Bosch-Vermeulen H, de Groot P, Hooiveld GJ, Bromhaar M, et al. (2008) The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Medical Genomics 1: 14-30.
24. Bligh EG, Dyer WJ. (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
25. Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, et al. (2005) Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289: E829-E838.
26. van Dijk TH, Boer TS, Havinga R, Stellaard F, Kuipers F, et al. (2003) Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. Anal Biochem 322: 1-13.
27. den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, et al. (2013) Gutderived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 305: G900-910.
28. Lee WN, Byerley LO, Bergner EA, Edmond J. (1991) Mass isotopomer analysis: Theoretical and practical considerations. Biol Mass Spectrom 20: 451-458.
29. Lasdon LS, Waren AD, Jain A, Ratner M. (1978) Design and testing of a generalized reduced gradient code for nonlinear programming. ACM Trans Math Softw 4: 34-50.
30. Landin K, Holm G, Tengborn L, Smith U. (1992) Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 56: 1061-1065.
31. Cicero AFG, Derosa G, Bove M, Imola F, Borghi C, et al. (2010) Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA step 2 diet. Mediterr J Nutr Metab 3: 47-57.
32. Lin HV, Frassetto A, Kowalik EJJ, Nawrocki AR, Lu MM, et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7: e35240.
33. Levrat MA, Rémésy C, Demigné C. (1991) High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J Nutr 121: 1730-1737.
34. Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, et al. (2009) Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. J Biol Chem 284: 34036-34044.
35. Sakakibara S, Yamauchi T, Oshima Y, Tsukamoto Y, Kadowaki T. (2006) Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KKA( y) mice. Biochem Biophys Res Commun 344: 597-604.
36. Yamashita H, Fujisawa K, Ito E, Idei S, Kawaguchi N, et al. (2007) Improvement of obesity and glucose tolerance by acetate in type 2 diabetic otsuka long-evans tokushima fatty (OLETF) rats. Biosci Biotechnol Biochem 71: 1236-1243.
37. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN. (2005) Insulinsensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82: 559-567.
38. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. (2010) Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 1801: 1175-1183.
39. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, et al. (2013) The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 4.
40. Yi TM, Huang Y, Simon MI, Doyle J. (2000) Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci U S A 97: 4649-4653.
41. Muzzey D, Gómez-Uribe CA, Mettetal JT, van Oudenaarden A. (2009) A systems-level analysis of perfect adaptation in yeast osmoregulation. Cell 138: 160-171.
42. Sellin JH. (1999) SCFAs: The enigma of weak electrolyte transport in the colon. News Physiol Sci 14: 58-64.
43. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, et al. (2012) Host-gut microbiota metabolic interactions. Science 336: 1262-1267.